Breast Cancer, Early-Onset
Conditions
Keywords
follow-up, mobile software, early breast cancer
Brief summary
Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. At 12 months the patients were asked their preference which was the primary end-point. At baseline, 6 months and 12 months the patients answered the other questionnaires.
Detailed description
Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. The primary end point was to find out patient preference for the modality of surveillance. Secondary endpoints were patient satisfaction, symptoms, quality of life and cost of follow-up during surveillance modalities. At 12 months the patients were asked their preference for the follow-up modality of early breast cancer. At baseline, 6 months and 12 months the patients answered the other questionnaires on quality of life, symptoms, patient satisfaction and use of other health-care services. Information on the cost of follow-up was gathered from the hospital and other registries.
Interventions
The patients were randomized to use mobile software or telephone calls as the follow-up modality for early breast cancer
Sponsors
Study design
Intervention model description
Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. At 12 months the patients were asked their preference. At baseline, 6 months and 12 months the patients answered the other questionnaires on patient satisfaction, quality of life, symptoms and use of other healthcare services.
Eligibility
Inclusion criteria
* Adult patients with early breast cancer after primary treatment including also radiotherapy (the patients were randomized at the final visit of radiotherapy)
Exclusion criteria
* not able to use a computer * another malignancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient preference for follow-up modality | At 12 months during follow-up of early breast cancer | Questionnaire of patient preference |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life during follow-up modality | At baseline, 6 months and 12 months | Quality of life questionnaires |
| Patient satisfaction | At 6 months and 12 months | Patient satisfaction questionnaires |
| Symptoms | At baseline, 6 months and 12 months | Symptom questionnaire |
| Use of other healthcare services | At 6 months and 12 months | Questionnaire |